医学
药物治疗
肠易激综合征
重症监护医学
内科学
作者
Mariana Hollanda Martins da Rocha,André Dong Won Lee,Márcia Lúcia de Mário Marin,Salomão Faintuch,Asher Mishaly,Joel Faintuch
标识
DOI：10.1080/14656566.2020.1724959
摘要
GLP-2 analogs are the first candidates from a pioneering pharmacotherapic family within the SBS framework, namely disease-modifying, absorption-restoring agents. This family of drugs, potentially applicable in all contexts of severe intestinal loss, could become the therapeutic benchmark of the near future.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
学霸业
aa
神勇映雁
Criminology34
机灵的沂
Nole
GingerF
XX
OK
芽芽
一大群
111zzzzzz
Banff
积极凌旋
渡人舟
阿水
DW
herococa
DIVINEDC
Harry
皖公网安备34019202002308
